Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Five sudden signs and symptoms of stroke

Stroke is the fourth-leading cause of death in the United States. Each year an estimated 795,000 people in this country experience a stroke. That's approximately the equivalent of every man, woman and child living in Anaheim and Long Beach combined.

3 May 2013

Small device implanted in the brain predicts epilepsy seizures in humans

A small device implanted in the brain has accurately predicted epilepsy seizures in humans in a world-first study led by Professor Mark Cook, Chair of Medicine at the University of Melbourne and Director of Neurology at St Vincent's Hospital.

3 May 2013

Researchers awarded grant to reduce higher rates of stroke among underserved populations

UCLA researchers and their partners across Los Angeles County have been awarded an $11 million grant to fund research on community-based interventions to reduce the higher rates of stroke and death from stroke among disadvantaged Hispanics, African Americans and Asian-Americans.

2 May 2013

AMGA, AMGF unveil two major resources to improve high blood pressure control

...

2 May 2013

Lowering door-to-balloon times helps benefit STEMI patients, study finds

While all heart attacks have the potential to be deadly, one type is referred to as the "widow maker" because of its high risk of death. A ST segment elevation myocardial infarction is a severe type of heart attack that occurs when a blockage in a coronary artery causes heart muscle to die; without prompt treatment risk of fatality increases dramatically. Coronary angioplasty, or percutaneous coronary intervention, is the most common emergency treatment for STEMI.

30 Apr 2013

UAB study suggests Mediterranean diet may be linked to preserving memory, thinking abilities

A University of Alabama at Birmingham study suggests that the Mediterranean diet, which urges consuming foods that contain omega-3 fatty acids found in fish, chicken and salad dressing, and avoiding saturated fats, meat and dairy foods, may be linked to preserving memory and thinking abilities.

30 Apr 2013

Gene study may uncover regulatory network that influences development of cardiovascular disease

University of North Carolina researchers have discovered that disrupting a gene that acts as a regulatory switch to turn on other genes can keep blood vessels from forming and developing properly.

30 Apr 2013

Naturopathic lifestyle counselling helps reduce risk of cardiovascular disease

Counselling and treatment with naturopathic care as well as enhanced usual care reduced the prevalence of metabolic syndrome, a risk factor for heart disease, by 17% over a year for participants in a randomized controlled trial published in CMAJ.

30 Apr 2013

New research shows more than a third of stroke patients don't get to hospital by ambulance

More than a third of stroke patients don't get to the hospital by ambulance, even though that's the fastest way to get there, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

30 Apr 2013

Educational cartoon boosts worm infection prevention

Researchers in China have found that a health education package targeted at schoolchildren can improve hygiene behaviors and reduce the incidence of soil-transmitted helminth infection.

29 Apr 2013

MRSA circulation among children greatest in hospitals

The hospital environment remains the most common source of methicillin-resistant Staphylococcus aureus bacteria, show results from a systematic review and meta-analysis looking at nasal colonization in different groups of children.

29 Apr 2013

Undetected arrhythmia could underlie some wake-up strokes

Unrecognized atrial fibrillation could be a cause of some wake-up strokes, say researchers who found an increased prevalence of the arrhythmia in patients who had stroke symptoms on waking.

29 Apr 2013

Colombian antenatal HIV testing rates reveal health insurance paradox

The introduction of subsidized health insurance for poor people in Colombia resulted in decreased access to HIV tests in antenatal care, research shows.

29 Apr 2013

Ocular tuberculosis presents a diagnostic challenge

Mycobacterial ocular inflammation typically arises without concomitant systemic or pulmonary disease and should be suspected in patients who do not respond to anti-inflammatory therapy.

29 Apr 2013

Osteomyelitis guidelines push pediatric care

US clinicians have demonstrated the benefits of multidisciplinary evidence-based guidelines for the treatment of children with osteomyelitis.

29 Apr 2013

CVRx enrolls first patient in Barostim HOPE4HF clinical trial

CVRx, Inc., a private medical device company, announced the first patient enrolled in the Barostim HOPE4HF clinical trial. The study is evaluating the effectiveness and safety of CVRx's Barostim neo in heart failure patients.

29 Apr 2013

UK’s health performance: an interview with Prof. Murray, University of Washington

Rates of premature mortality in the UK have been falling steadily, but the pace of decline is not as fast as in many other high-income countries, such as Australia. In that sense, the UK lags behind.

29 Apr 2013

CHMP recommends approval of NUEDEXTA for treatment of pseudobulbar affect

Avanir Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate), recommending NUEDEXTA be approved for the treatment of pseudobulbar affect, irrespective of neurologic cause.

29 Apr 2013

Protein C4BP is possibly suitable as transporter for drugs, say researchers

The protein C4BP is similar to a spider in its spatial form with eight "arms". The structure of the "spider body" has recently been described in detail by researchers from the Helmholtz Centre for Infection Research in Braunschweig and the Technische Universit-t Darmstadt.

29 Apr 2013

Practical guidelines on the use of new oral anticoagulants

A practical guide on the use of the new oral anticoagulants has been produced by the European Heart Rhythm Association of the European Society of Cardiology.

29 Apr 2013